OUR VISION By addressing the unmet medical needs of our
patients with paradigm-shifting therapeutics
WE ASPIRE TO CONQUER CANCER

Clinical Program

P-TEFb is an intracellular protein composed of two subunits, CDK9 and Cyclin-T. CDK9 is a transcriptional kinase that plays a central role in one of the processes that cancer cells use to survive and thrive: increased expression of cancer-promoting genes (eg, MYC and MCL1).
Learn more

Pipeline

VINCERX PHARMA
NEWS

Vincerx Pharma Reports Third Quarter 2022 Financial Results and Provides a Corporate Update

Menu